Skip to main content
logo
Solvonis Therapeutics plc (LON:SVNS)
London flag London · Delayed Price · Currency is GBP · Price in GBX
0.1150
-0.0050 (-4.17%)
Sep 4, 2026, 4:07 PM GMT

Solvonis Therapeutics Financials Overview

Millions GBP. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---0.590.540.38
Revenue Growth
---8.30%44.37%-27.80%
Gross Profit
---0.140.30.17
Operating Income
-3.58-3.58-1.51-2.4-2.7-1.62
Net Income
-5.74-5.74-1.59-3.12-2.71-1.64
Earnings Per Share
-0.00-0.00-0.00-0.03-0.03-0.02
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.721.720.760.161.640.6
Total Debt
0.080.08-0.030.020.96
Net Cash (Debt)
1.651.650.760.121.62-0.36
Net Cash Growth
0.18%117.30%525.62%-92.52%--
Net Cash Per Share
0.000.000.000.000.02-0.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-3.27-3.27-1.13-1.24-2.36-0.44
Capital Expenditures
----0.22-0.72-0
Free Cash Flow
-3.27-3.27-1.13-1.45-3.08-0.44
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---24.02%55.35%46.12%
Operating Margin
----408.18%-498.34%-431.96%
Pretax Margin
----531.52%-499.08%-435.62%
Profit Margin
----531.52%-499.08%-435.62%
FCF Margin
----247.70%-567.90%-116.44%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---1.0226.70-